Targeting NOTCH1 in hematopoietic malignancy.

Abstract excerpt

NOTCH1 is a well-validated target in hematopoietic malignancy, with NOTCH1 activating mutations identified in more than 50% of T-cell acute lymphoblastic leukemias. Moreover, a recent report has identified NOTCH1 activating mutations in 12% of chronic lymphocytic leukemias. While the frequency of NOTCH1 mutations and the well-documented role of this protein in the pathogenesis and maintenance of T-ALL support...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to NOTCH1 gene
• Share to Hematologic Neoplasms
• Share to Mutation